Development and Evaluation Valsartan Containing Controlled Release Pellets

The concept of controlled drug delivery has been explored for the delivery of drugs for prolong period of time for the past few years. This type of drug delivery has proved to provide a solution to several problems encountered in the repeated administration of such drugs. Utilizing the concept of incorporating drug in to the polymer matrices and extend the drug release for prolong period of time. The present study is an attempt to formulate and evaluate sustained release pellets of valsartan, in view to improve patient compliance and therapeutic action. To increase therapeutic efficacy, reduce frequency of administration and for better patient compliance once daily sustained release valsartan pellets proposed for extended-release dosage forms as it offers several manufacturing and biopharmaceutical advantages. The spherical shape and low surface area to volume ratio of pellets are advantageous for uniform film coating. Ethylcellulose in combination with Eudragit NE 30D was employed in this research to sustain the drug release for 24 hours by using layering technology. Here, Ethylcellulose acts as a release retarding polymer and Eudragit NE 30D acts as a film forming agent.

Controlled release, Pellets, Valsartan, Coating pellets, Multiperticulate system

1. Aulton M.E, international student Edition, . Pharmaceutics- The Science of Dosage form design, page no. 129-191. Churchill Livingston, 2001. [Google Scholar] [Crossref]

2. Bechgaard, H., Nielesen, G.H., 1978. Controlled-release multiple units and single-unit doses. A literature review. Drug Dev. Ind. Pharm. 4, 53-67. [Google Scholar] [Crossref]

3. Borra V, Patil A, Palaskar G and Pol S. D, “Formulation and evaluation of different synthetic and natural polmers on high dose metoprolol succinate”, International journal of pharmaceutical science, 2018; 55-60. [Google Scholar] [Crossref]

4. Bramankar D M and Jaiswal S B, ‘Biopharmaceutics and pharmacokinetics a treatise’ 1st ed, Vallabh prakashan, Delhi, page no. 335-337, 1995. [Google Scholar] [Crossref]

5. Chein, Y. W. Rate control drug delivery systems: controlled release vs sustained release. Med. Prog. Techn. page no. 15, 21-46, 1989. [Google Scholar] [Crossref]

6. Dreu R, Llic L, Srcic S, (2011), “Development of a multiple-unit tablet containing enteric- coated pellets”. Pharmaceutical Development and Technology, 04/2011; 16(2):118-26. [Google Scholar] [Crossref]

7. Nadeem siddiqui, Asif husain, Lakshita Chaudhary, M. Shamsher, Journal of applied pharmaceutical science 01 (04); 2011;12-19. [Google Scholar] [Crossref]

8. P.K. Puranik, S. D. Pol, S.B. Patil, International Journal of pharmaceutical sciences and reasearch 2015;vol.6: Issue1. [Google Scholar] [Crossref]

9. Pan X, Chen M et al, “Novel compaction techniques with pellet-containing granules”. European Journal Of Pharmaceutics And Biopharmaceutics, 2010;436-42. [Google Scholar] [Crossref]

10. Sandberg, A., Ragnarsson, G., Jonsson, U.E., Sjogren, J., 1988. Design of a new multiple-unit controlledrelease formulation of metoprolol-metoprolol CR. Eur. J. Clin. Pharmacol. 33, S3-S7. [Google Scholar] [Crossref]

11. Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, “Development and evaluation of a novel pellet-based tablet system for potential colon delivery of budesonide”, Iran Journal of Drug Delivery, 2012. [Google Scholar] [Crossref]

12. Chowdary, K. P. R., Lingaraju S Danki and Hiremath, S. N., Der Pharmacia Lettre., 2010;2(2 (: 221-236. [Google Scholar] [Crossref]

13. Michael.U. Uhumwangho and Roland. S. Okor , Acta Poloniae Pharmaceutica Drug Research, 2007,64(1) , 73-79. [Google Scholar] [Crossref]

• Development and Evaluation of Floating Alginate Beads of Esomeprazole
• Determination of pKa Value for Ranolazine and Atenolol Using UV Spectroscopy
• The Science of Sustained-Release Medications
• Development of Proteomics in Clinical Medicine
• Advances on Quinoline Derivatives: A Review of Synthesis and Biological Activities